These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25699116)

  • 21. Impact of sitagliptin combination therapy and hypoglycemia in Japanese patients with type 2 diabetes: a multi-center retrospective observational cohort study.
    Saito T; Ohmura H; Nojiri S; Daida H
    J Pharm Health Care Sci; 2020; 6():13. PubMed ID: 32518665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of 6-month sitagliptin treatment on metabolic parameters in diabetic patients taking oral glucocorticoids: a retrospective cohort study.
    Katsuyama H; Sako A; Adachi H; Hamasaki H; Yanai H
    J Clin Med Res; 2015 Jun; 7(6):479-84. PubMed ID: 25883713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sitagliptin: Is It Effective in Routine Clinical Practice?
    Mohan Dallumal R; Chua SS; Wu DB; Vethakkan SR
    Int J Endocrinol; 2015; 2015():950571. PubMed ID: 26089904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erratum to: Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus and comparison of hypoglycemic action of concomitant medications: a subanalysis of the JAMP study.
    Ujihara N; Sakura H; Hashimoto N; Sasamoto K; Ohashi H; Hasumi S; Kasahara T; Tomonaga O; Nunome H; Honda M; Iwamoto Y;
    Diabetol Int; 2018 Feb; 9(1):66-67. PubMed ID: 30605174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erratum to: Safety and Tolerability of Sitagliptin in Type 2 Diabetes: Pooled Analysis of 25 Clinical Studies.
    Engel SS; Round E; Golm GT; Kaufman KD; Goldstein BJ
    Diabetes Ther; 2013 Dec; 4(2):487. PubMed ID: 23838842
    [No Abstract]   [Full Text] [Related]  

  • 26. Sitagliptin-Induced Arthralgias: A Case Report.
    Jackson R; Sbeiti I; Vincent G
    Clin Diabetes; 2020 Jul; 38(3):315-317. PubMed ID: 32699485
    [No Abstract]   [Full Text] [Related]  

  • 27. Erratum: efficacy and safety of dulaglutide versus sitagliptin after 52 weeks in type 2 diabetes in a randomized controlled trial (AWARD-5). Diabetes Care 2014;37:2149-2158.
    Nauck M; Weinstock RS; Umpierrez GE; Guerci B; Skrivanek Z; Milicevic Z
    Diabetes Care; 2015 Mar; 38(3):538. PubMed ID: 25715416
    [No Abstract]   [Full Text] [Related]  

  • 28. Review of empagliflozin monotherapy for previously untreated patients with type 2 diabetes mellitus: Comparison with sitagliptin.
    Cornell S
    Postgrad Med; 2015 Apr; 127(3):277-81. PubMed ID: 25724655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical utility and patient considerations in the use of the sitagliptin-metformin combination in Chinese patients.
    Du Q; Wang YJ; Yang S; Han P
    Patient Prefer Adherence; 2015; 9():281-7. PubMed ID: 25709414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erratum to: Comparison of Treatment with Sitagliptin or Sulfonylurea in Patients with Type 2 Diabetes Mellitus and Mild Renal Impairment: A Post Hoc Analysis of Clinical Trials.
    Ommen ES; Xu L; O'Neill EA; Goldstein BJ; Kaufman KD; Engel SS
    Diabetes Ther; 2015 Mar; 6(1):97-8. PubMed ID: 25707480
    [No Abstract]   [Full Text] [Related]  

  • 31. Cost-Effectiveness Analysis of Incretin Therapy for Type 2 Diabetes in Spain: 1.8 mg Liraglutide Versus Sitagliptin.
    Pérez A; Mezquita Raya P; Ramírez de Arellano A; Briones T; Hunt B; Valentine WJ
    Diabetes Ther; 2015 Mar; 6(1):61-74. PubMed ID: 25742705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Randomized Clinical Trial to Evaluate the Efficacy and Safety of Co-Administration of Sitagliptin with Intensively Titrated Insulin Glargine.
    Mathieu C; Shankar RR; Lorber D; Umpierrez G; Wu F; Xu L; Golm GT; Latham M; Kaufman KD; Engel SS
    Diabetes Ther; 2015 Jun; 6(2):127-42. PubMed ID: 25820927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetes-related quality measure attainment: canagliflozin versus sitagliptin based on a pooled analysis of 2 clinical trials.
    Bailey RA; Vijapurkar U; Meininger GE; Rupnow MF; Blonde L
    Am J Manag Care; 2014 Dec; 20(13 Suppl):s296-305. PubMed ID: 25734218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of sitagliptin against renal ischemia reperfusion injury in rats.
    Nuransoy A; Beytur A; Polat A; Samdanci E; Sagir M; Parlakpinar H
    Ren Fail; 2015 May; 37(4):687-93. PubMed ID: 25703705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of sitagliptin added to insulin in Japanese patients with type 2 diabetes: the EDIT randomized trial.
    Sato S; Saisho Y; Kou K; Meguro S; Tanaka M; Irie J; Kawai T; Itoh H
    PLoS One; 2015; 10(3):e0121988. PubMed ID: 25816296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sitagliptin/Simvastatin: a first combination tablet to treat type 2 diabetes and hypercholesterolemia--a review of its characteristics.
    Ramadan WH; Kabbara WK
    Vasc Health Risk Manag; 2015; 11():125-32. PubMed ID: 25709467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of sitagliptin and rosuvastatin combination on vascular endothelial dysfunction in type-2 diabetes.
    Nade VS; Kawale LA; Patel KM
    Indian J Pharm Sci; 2015; 77(1):96-102. PubMed ID: 25767324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy and safety of initial treatment with glimpeiride versus sitagliptin in type 2 diabetes].
    Tamez-Pérez HE;
    Rev Med Inst Mex Seguro Soc; 2015; 53(2):142-8. PubMed ID: 25760742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Where does combination therapy with an SGLT2 inhibitor plus a DPP-4 inhibitor fit in the management of type 2 diabetes?
    Abdul-Ghani M
    Diabetes Care; 2015 Mar; 38(3):373-5. PubMed ID: 25715413
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of sitagliptin on coronary atherosclerosis evaluated using integrated backscatter intravascular ultrasound in patients with type 2 diabetes: rationale and design of the TRUST study.
    Nozue T; Fukui K; Koyama Y; Fujii H; Kunishima T; Hikita H; Hibi K; Miyazawa A; Michishita I
    Heart Vessels; 2016 May; 31(5):649-54. PubMed ID: 25794984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.